WO2025168481 - IMINO-ANTHRACYCLINE DERIVATIVES AND METHODS
National phase entry is expected:
Publication Number
WO/2025/168481
Publication Date
14.08.2025
International Application No.
PCT/EP2025/052655
International Filing Date
03.02.2025
Title **
[English]
IMINO-ANTHRACYCLINE DERIVATIVES AND METHODS
[French]
DÉRIVÉS D'IMINO-ANTHRACYCLINE ET PROCÉDÉS
Applicants **
NERVIANO MEDICAL SCIENCES S.R.L.
Inventors
SALSA, Matteo
FAIARDI, Daniela
ORSINI, Paolo
Priority Data
24155853.5
05.02.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2586 | |
| EPO | Filing, Examination, Granting | 12763 | |
| Japan | Filing, Examination, Granting | 2359 | |
| South Korea | Filing, Examination, Granting | 2405 | |
| USA | Filing, Examination, Granting | 9140 |
Total:
29,253
Contact Us
Abstract[English]
The present invention provides a novel class of cytotoxic imino-anthracycline derivatives, methods for their preparation, pharmaceutical composition containing them and use thereof in treating certain mammalian tumors. The present invention also provides imino-anthracycline-linker reagents suitable for conjugation with carriers and methods for their preparation.[French]
La présente invention concerne une nouvelle classe de dérivés d'imino-anthracycline cytotoxiques, des procédés pour leur préparation, une composition pharmaceutique les contenant et leur utilisation dans le traitement de certaines tumeurs chez les mammifères. La présente invention concerne également des réactifs de liaison imino-anthracycline appropriés pour réaliser une conjugaison avec des supports et des procédés pour leur préparation.